Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $467.89 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $177.79 | 12 | $0 (2024) |
| Exact Sciences Corporation | $58.35 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $54.87 | 4 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $37.60 | 3 | $0 (2020) |
| Astellas Pharma US Inc | $36.51 | 2 | $0 (2024) |
| Lilly USA, LLC | $30.39 | 2 | $0 (2019) |
| GlaxoSmithKline, LLC. | $26.78 | 2 | $0 (2019) |
| ABBVIE INC. | $18.77 | 1 | $0 (2024) |
| Amarin Pharma Inc. | $14.20 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $12.63 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $91.63 | 4 | Exact Sciences Corporation ($33.52) |
| 2023 | $92.09 | 5 | Novo Nordisk Inc ($67.26) |
| 2020 | $27.87 | 2 | Astellas Pharma US Inc ($14.54) |
| 2019 | $134.93 | 10 | Novo Nordisk Inc ($93.16) |
| 2018 | $65.29 | 5 | AstraZeneca Pharmaceuticals LP ($26.83) |
| 2017 | $56.08 | 4 | Lilly USA, LLC ($16.95) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $33.52 | General |
| Category: Oncology | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Biological | ||||||
| 02/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Diabetes | ||||||
| 07/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Obesity | ||||||
| 06/29/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Obesity | ||||||
| 05/24/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Diabetes | ||||||
| 04/13/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Oncology | ||||||
| 03/21/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Diabetes | ||||||
| 01/27/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/06/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: UROLOGY | ||||||
| 11/18/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
| 09/23/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Diabetes | ||||||
| 09/09/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Diabetes | ||||||
| 08/20/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 07/15/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Diabetes | ||||||
| 06/24/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: VACCINES | ||||||
| 05/24/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: Diabetes | ||||||
| 03/18/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/11/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Diabetes | ||||||
| 01/14/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Diabetes | ||||||
| 09/24/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Hypertriglyceridemia | ||||||
| 07/30/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 405 | 541 | $149,567 | $43,292 |
| 2022 | 9 | 326 | 442 | $126,788 | $36,589 |
| 2021 | 4 | 151 | 241 | $74,661 | $21,820 |
| 2020 | 3 | 95 | 107 | $27,507 | $5,628 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 208 | $75,504 | $20,803 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 143 | $35,321 | $8,949 | 25.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 55 | 55 | $21,835 | $7,821 | 35.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 23 | 23 | $2,139 | $1,654 | 77.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $7,163 | $1,536 | 21.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $4,368 | $1,084 | 24.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $980.00 | $951.16 | 97.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 35 | $2,065 | $411.52 | 19.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 24 | $192.00 | $81.84 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 180 | $65,340 | $17,807 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 99 | $24,453 | $6,993 | 28.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 43 | 43 | $17,071 | $6,284 | 36.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $12,122 | $2,623 | 21.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $4,004 | $1,000 | 25.0% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 11 | 11 | $814.00 | $750.66 | 92.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $700.00 | $674.49 | 96.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 31 | 36 | $2,124 | $387.28 | 18.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 16 | 20 | $160.00 | $68.51 | 42.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 69 | 138 | $50,094 | $13,854 | 27.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 57 | $14,079 | $4,265 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 23 | 23 | $9,131 | $3,429 | 37.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 20 | 23 | $1,357 | $270.80 | 20.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 47 | $11,562 | $2,448 | 21.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 35 | $12,705 | $1,641 | 12.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 23 | 25 | $3,240 | $1,540 | 47.5% |
About Dr. Olympia Sophias, D.O
Dr. Olympia Sophias, D.O is a Family Medicine healthcare provider based in Rockaway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2013. The National Provider Identifier (NPI) number assigned to this provider is 1174961403.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Olympia Sophias, D.O has received a total of $467.89 in payments from pharmaceutical and medical device companies, with $91.63 received in 2024. These payments were reported across 30 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($467.89).
As a Medicare-enrolled provider, Sophias has provided services to 977 Medicare beneficiaries, totaling 1,331 services with total Medicare billing of $107,329. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Rockaway, NJ
- Active Since 06/09/2013
- Last Updated 02/25/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174961403
Products in Payments
- Ozempic (Drug) $108.38
- Cologuard Collection Kit (Device) $58.35
- FARXIGA (Drug) $41.53
- Rybelsus (Drug) $35.51
- Wegovy (Drug) $33.90
- JANUVIA (Drug) $25.10
- Veozah (Drug) $21.97
- QULIPTA (Drug) $18.77
- TRULICITY (Drug) $16.95
- MYRBETRIQ (Drug) $14.54
- BEXSERO (Biological) $14.29
- Vascepa (Drug) $14.20
- JARDIANCE (Drug) $13.44
- BEVESPI AEROSPHERE (Drug) $13.34
- INVOKANA (Drug) $12.63
- ASMANEX (Drug) $12.50
- TRELEGY ELLIPTA (Drug) $12.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Rockaway
Dr. Christopher Horn, D.o, D.O
Family Medicine — Payments: $9,828
Christopher Heitzman, D.o, D.O
Family Medicine — Payments: $1,924
Dr. Aadya Sharma, Md, MD
Family Medicine — Payments: $289.80
Dr. Oluwatoyin Fapohunda-Adekola, Md, MD
Family Medicine — Payments: $190.96
Dr. Ian Brodrick, M.d, M.D
Family Medicine — Payments: $145.14
Christine Sedlacek, Md, MD
Family Medicine — Payments: $104.64